Praxis Precision Medicines Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Praxis Precision Medicines Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Boston
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- PRAX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001689548
Board of directors
-
Dean J. Mitchell · DirectorSince 2023
-
Gregory Norden · DirectorSince 2023
-
Jeffrey B. Kindler · DirectorSince 2026
-
Jeffrey Chodakewitz · DirectorSince 2023
-
Jill DeSimone · DirectorSince 2023
-
Marcio Souza · Director · Chief Executive OfficerSince 2023
-
Merit Ester Cudkowicz · DirectorSince 2023
-
Stuart A. Arbuckle · DirectorSince 2026
-
William D. Young · DirectorSince 2023
Chief executives
Marcio Souza
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of June 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
85.5%
-
98.8%
-
99.5%
Board connections
6 of this board's directors also sit on 9 other boards.
- via Dean J. Mitchell and Jeffrey B. Kindler
- via Jeffrey Chodakewitz
- via Stuart A. Arbuckle
- via William D. Young
- via Jeffrey B. Kindler
- via Stuart A. Arbuckle
- via Gregory Norden
- via Jeffrey Chodakewitz
- via Gregory Norden
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $44,274,014
- 28 sales by 4 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 8, 2026 | Marcio Souza Director, Officer (Chief Executive Officer) | Gift | −20,521 | — | — |
| Jul 8, 2026 | Marcio Souza Director, Officer (Chief Executive Officer) | Gift | −2,600 | — | — |
| Jun 24, 2026 | Jill DeSimone Director | Option exercise | +8,566 | $44.25 | $379,046 |
| Jun 24, 2026 | Jill DeSimone Director | Option exercise | +3,034 | $147.30 | $446,908 |
| Jun 24, 2026 | Jill DeSimone Director | Open-market sale | −10 | $301.44 | $3,014 |
| Jun 24, 2026 | Jill DeSimone Director | Open-market sale | −120 | $303.13 | $36,376 |
| Jun 24, 2026 | Jill DeSimone Director | Open-market sale | −320 | $305.31 | $97,699 |
| Jun 24, 2026 | Jill DeSimone Director | Open-market sale | −683 | $306.77 | $209,524 |
| Jun 24, 2026 | Jill DeSimone Director | Open-market sale | −1,240 | $308.24 | $382,218 |
| Jun 24, 2026 | Jill DeSimone Director | Open-market sale | −999 | $309.38 | $309,071 |
| Jun 24, 2026 | Jill DeSimone Director | Open-market sale | −1,750 | $310.89 | $544,058 |
| Jun 24, 2026 | Jill DeSimone Director | Open-market sale | −2,854 | $311.91 | $890,191 |
| Jun 24, 2026 | Jill DeSimone Director | Open-market sale | −1,004 | $312.83 | $314,081 |
| Jun 24, 2026 | Jill DeSimone Director | Open-market sale | −504 | $313.66 | $158,085 |
| Jun 24, 2026 | Jill DeSimone Director | Open-market sale | −1,279 | $314.90 | $402,757 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.